CTI BIOPHARMA CORP - COM (CTIC) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2016 to Q3 2023

Type / Class
Equity / COM
Symbol
CTIC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$474,241 0
2023 Q2 102,040 $474,241 -$472,927,639 $6.64 2
2023 Q1 113,145,145 $475,143,333 +$35,158,478 $4.20 131
2022 Q4 101,391,119 $609,353,626 +$49,703,145 $6.01 142
2022 Q3 93,341,618 $543,213,500 +$57,718,638 $5.82 126
2022 Q2 83,016,168 $495,627,852 +$170,935,573 $5.97 108
2022 Q1 52,468,722 $245,057,464 +$62,459,641 $4.67 81
2021 Q4 47,715,236 $118,329,629 -$21,155,836 $2.48 53
2021 Q3 54,116,036 $159,641,000 +$2,660,412 $2.95 50
2021 Q2 53,244,611 $133,114,000 +$23,326,834 $2.50 41
2021 Q1 43,334,791 $126,106,096 -$1,382,718 $2.91 49
2020 Q4 43,689,439 $140,676,000 +$11,379,799 $3.22 53
2020 Q3 39,573,104 $85,081,538 +$11,162,086 $2.15 28
2020 Q2 34,459,341 $39,971,290 -$2,495,859 $1.16 31
2020 Q1 36,617,461 $33,686,480 +$10,764,385 $0.92 27
2019 Q4 24,890,406 $39,226,841 -$105,711 $1.58 29
2019 Q3 25,174,714 $21,025,121 -$1,747,004 $0.83 32
2019 Q2 27,263,677 $23,420,259 -$2,791,365 $0.86 44
2019 Q1 30,583,372 $29,665,463 -$3,826,909 $0.97 57
2018 Q4 34,906,130 $25,632,676 -$2,728,955 $0.73 60
2018 Q3 35,503,203 $76,676,672 -$28,290,957 $2.16 71
2018 Q2 40,234,843 $200,435,084 +$20,847,215 $4.98 73
2018 Q1 36,288,963 $141,525,117 +$65,075,476 $3.90 58
2017 Q4 19,681,311 $52,741,081 +$3,613,458 $2.68 37
2017 Q3 18,316,147 $58,430,096 -$406,478 $3.19 32
2017 Q2 18,424,425 $60,969,066 +$38,560,009 $3.31 28
2017 Q1 6,673,934 $28,030,084 +$26,966,855 $4.20 35
2016 Q4 387,772 $156,000 +$156,000 $0.40 3